Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
19 Aug 2025
Targeted Therapies Offer Hope in Inflammatory Myopathies
Idiopathic inflammatory myopathies are complex immune-mediated disorders with multisystem involvement, and recent advances are reshaping both classification and treatment approaches.
Novartis to tackle rare disease diagnosis with AI
Novartis is partnering with Atropos Health to develop AI models that accelerate rare disease diagnosis, starting with a rare blood disorder.
19 Aug 2025
Elexacaftor-Tezacaftor-Ivacaftor Cuts Liver Complications in Cystic Fibrosis
The availability of elexacaftor–tezacaftor–ivacaftor (ETI) has been associated with a marked reduction in cystic fibrosis liver disease (CFLD) progression, according to a nationwide analysis.
19 Aug 2025
Novel Combination Therapy Shows Rapid Improvement in Liver Health in Patients with MASLD
Silymarin, vitamin E, and phospholipids combination therapy effectively reduces liver steatosis, fibrosis, and metabolic risk in MASLD.
19 Aug 2025
Smoking Cessation Improves Recovery in Substance Use Disorder
Discover how stopping smoking may improve recovery from other addictions and why treatment programmes should integrate both.
19 Aug 2025
One in Three Patients With Rheumatoid Arthritis Intolerant to Methotrexate
A new study reveals that over a third of Indian rheumatoid arthritis patients experience methotrexate intolerance, with many reporting symptoms like nausea and abdominal discomfort.
19 Aug 2025
No Clear Benefit to Early Endoscopy in Oesophageal Variceal Bleeding
A Vietnamese retrospective study challenges the push for endoscopy within 12 hours in patients with esophageal variceal bleeding.
19 Aug 2025
Triamcinolone Outperforms Methotrexate in Treating Patchy Alopecia
Discover a study comparing intralesional triamcinolone and methotrexate for alopecia areata, revealing superior regrowth and patient satisfaction with triamcinolone.
18 Aug 2025
TriCLASP Study Confirms Safety and Symptom Improvement with Transcatheter Tricuspid Repair
TriCLASP study confirms PASCAL T-TEER safely reduces tricuspid regurgitation and improves symptoms and quality of life.
18 Aug 2025
When Surgery Becomes Essential in Severe
C. difficile
Severe Clostridioides difficile infection (CDI) can progress rapidly to organ failure and sepsis, and while most patients respond to antibiotic therapy, a minority face life-threatening disease that may require surgical intervention.
←
1
2
3
…
206
207
208
209
210
211
212
…
1,474
1,475
1,476
→
We’ve noticed you’re accessing
from
North/South America.
View
View